← Open Payments lookup

DENISE SPEICH: Open Payments

NPI 1023160447 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,065 in 68 payments from 16 companies in 2025. Trend: 2023 $1,062 · 2024 $1,577 · 2025 $1,065

Food & beverage: $1,056Education: $9
CompanyPaymentsAmount
Janssen Biotech, Inc.22$258
Celltrion USA Inc.5$180
Takeda Pharmaceuticals U.S.A., Inc.10$154
ABBVIE INC.12$152
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$60
Madrigal Pharmaceuticals2$42
QOL Medical, LLC2$41
Ipsen Biopharmaceuticals, Inc2$40
Phathom Pharmaceuticals, Inc.3$27
GENZYME CORPORATION1$22

Products named: TREMFYA, ENTYVIO, ZYMFENTRA, RINVOQ, XIFAXAN, VEGZELMA, REZDIFFRA, Sucraid.

Industry payments across NE — which companies pay providers there.